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ABSTRACT 
In the 40 years since the essentiality of polyunsaturated fatty acids (PUFA) in fish was first 
established by determining quantitative requirements for 18:3n-3 and 18:2n-6 in rainbow trout, 
essential fatty acid (EFA) research has gone through distinct phases. For 20 years the focus was 
primarily on determining qualitative and quantitative EFA requirements of fish species. Nutritional 
and biochemical studies showed major differences between fish species based on whether C18 
PUFA or long-chain (LC)-PUFA were required to satisfy requirements. In contrast, in the last 20 
years, research emphasis shifted to determining “optimal” levels of EFA to support growth of fish 
fed diets with increased lipid content and where growth expectations were much higher. This 
required greater knowledge of the roles and functions of EFA in metabolism and physiology, and 
how these impacted on fish health and disease. Requirement studies were more focused on early life 
stages, in particular larval marine fish, defining not only levels, but also balances between different 
EFA. Finally, a major driver in the last 10-15 years has been the unavoidable replacement of fish oil 
and fishmeal in feeds and the impacts that this can have on n-3 LC-PUFA contents of diets and 
farmed fish, and the human consumer. Thus, dietary n-3 in fish feeds can be defined by three levels. 
Firstly, the minimum level required to satisfy EFA requirements and thus prevent nutritional 
pathologies. This level is relatively small and easy to supply even with today’s current high demand 
for fish oil. The second level is that required to sustain maximum growth and optimum health in 
fish being fed modern high-energy diets. The balance between different PUFA and LC-PUFA is 
important and defining them is more challenging, and so ideal levels and balances are still not well 
understood, particularly in relation to fish health. The third level is currently driving much research; 
how can we supply sufficient n-3 LC-PUFA to maintain the nutritional quality of farmed fish at the 
same level as 20 years ago, and similar or better than in wild fish? This level far exceeds the 
biological requirements of the fish itself and to satisfy it we require entirely new sources of n-3 LC-
PUFA. We cannot rely on the finite and limited marine resources that we can sustainably harvest or 
  3 
efficiently recycle. We need to produce n-3 LC-PUFA de novo and all possible options should be 
considered. 
 
Keywords: Fish oil; essential fatty acids; nutrition; health; metabolism; sustainability 
  4 
Highlights: 
1. Long-chain omega-3 fatty acids are essential nutrients for vertebrates including fish and 
humans, but they are a finite and limited resource. 
2. Dietary levels to satisfy metabolic requirements and sustain optimal growth and health 
in fish are relatively low, but supra-physiological levels are required to maintain high 
nutritional quality of farmed products.  
3. Aquaculture has an important role to play in the efficient use of existing supplies of 
long-chain omega-3 and their transfer to human consumers. 
4. For aquaculture to continue in this capacity, entirely new sources of long-chain omega-3 
fatty acids are required and, currently, transgenic oilseed crops represent the most viable 
option. 
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1. Introduction 
Fish accounted for 16.7 % of the global population’s intake of animal protein and 6.5 % of all 
protein consumed in 2010 (FAO, 2014). However, in addition to protein, fish are also important 
dietary sources of minerals including iodine and selenium, and vitamins such as A, D and E (Tacon 
and Metian, 2013). Arguably, of greatest importance for consumers in the developed world, fish 
and seafood are unique and rich sources of omega-3 (n-3) long-chain polyunsaturated fatty acids 
(LC-PUFA), particularly eicosapentaenoic (EPA; 20:5n-3) and docosahexaenoic (DHA; 22:6n-3) 
acids (Tur et al., 2012), that have well-known and generally accepted beneficial effects in a range of 
human pathologies including cardiovascular and inflammatory diseases, and an important role in 
neural development (Gil et al., 2012; Delgado-Lista et al, 2012; Campoy et al., 2012; Calder, 2013). 
However, marine fisheries worldwide are stagnating with 63 % of assessed fish stocks requiring 
rebuilding (Worm et al., 2009) and so, consequently, an increasing proportion of fish are farmed, 
accounting for almost half of all fish for human food in 2012 (FAO, 2014).  Feeds for farmed 
carnivorous species were traditionally based on fishmeal (FM) and fish oil (FO) and, while this 
practice was good for the supply of n-3 LC-PUFA (Sargent et al., 2002), the reliance on finite 
marine resources derived from capture fisheries was an unsustainable practice (Naylor et al., 2000; 
Tacon and Metian, 2009). Therefore, the continued growth of aquaculture was dependent upon the 
development of more sustainable feeds with alternative ingredients, generally derived from 
terrestrial agriculture, with important consequences for the supply of n-3 LC-PUFA (Gatlin et al., 
2007; Tocher, 2009; Turchini et al., 2011a). This short review summarises the important issues 
surrounding omega-3 LC-PUFA as key nutrients, particular in the context of aquaculture and its 
role in the provision of dietary n-3 LC-PUFA for the human consumer. In doing so, it aims to 
clarify the issues underpinning the use of marine ingredients and their replacement, highlighting the 
influence and limitations of fish metabolism, and critically assessing options for the future, 
sustainable supply of n-3 LC-PUFA. 
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2. Fish oil – Historical perspective, recent trends and current status 
The production and use of FO goes back to antiquity when it was the original liquid fuel and burnt 
in lamps for light, a process that converted n-3 LC-PUFA to CO2, or “greenhouse” gas. In the 20th 
century FO, including whale oil, was used extensively in margarine production that required 
hydrogenation and conversion of n-3 LC-PUFA to saturated and, even worse, trans-fatty acids. 
Now, in the 21st century the main use of FO is in feeds for aquaculture, primarily as a source of n-3 
LC-PUFA that are now prized for their health benefits, not only to the farmed fish itself, but also to 
the human consumers through the production of high-quality food. Although, FO has also been 
used in terrestrial animal feeds (pigs and poultry) and small amounts were always used for direct 
human consumption (particularly cod liver oil), history demonstrates that, in terms of n-3 LC-
PUFA, aquaculture represents arguably the best use of bulk FO to date.  
   However, there are constraints on the use of FO (and FM) in aquaculture. The primary constraint 
is that these are essentially finite marine resources with production necessarily limited through strict 
regulation of fishing and catch quotas (Shepherd and Jackson, 2012; Jackson and Shepherd, 2013). 
Production of FM and FO had been slightly declining in recent years, largely due to increased 
regulation and reduced quotas in South America, but this situation is appearing more stable (FAO, 
2012). The status of FO use in 2012, showed that around 75 % of total global supply was used in 
aquaculture, with 22% going for direct human consumption (IFFO, 2013) (Fig.1A). Over 80 % of 
FO used in aquaculture feeds was consumed by salmonids (62 %) and marine fish (19 %) (Fig.1B). 
Despite the continued growth of aquaculture (FAO, 2014), the use of FO in aquaculture was 
relatively stable over the last decade with, on average, around 0.8 mt being used (IFFO, 2013) 
(Fig.1C). Increased use of seafood and aquaculture by-products (including by-catch and trimmings 
etc.) to produce FM and, to a lesser extent, FO, has partially offset some of the reductions in 
production from whole fish as a result of increased restrictions on the reduction fisheries (Shepherd 
and Jackson, 2012; OECD-FAO, 2013). Production is also subject to environmental influences and, 
whereas the potential impact of climate change is not well understood (Callaway et al., 2012), acute 
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phenomena such as El Niño have well-known consequences and the next significant event will have 
major effect on FM and FO supply (FAO/GIEWS, 1997).    
Although, the finite and limited nature of FO production and supply is the main constraint to its use 
in aquaculture, there are other major factors (Bell and Waagbø, 2008). Sustainability issues are, of 
course, key drivers limiting overall supply, and these will have an increasing impact with the many 
initiatives currently being developed with respect to both national and international standards and 
certification of marine ingredients, particularly FM and FO products. In fisheries, International 
standards are being set by the Marine Stewardship Council (MSC; http://www.msc.org) that 
operates a certification programme promoting sustainable fishing practices, and similar national 
schemes also exist such as the UK’s Responsible Fishing Scheme (RFS; http://rfs.seafish.org). The 
Marine Ingredients Organisation (IFFO) also operates the IFFO-RS standard 
(http://www.iffo.net/iffo-rs), a certification programme to specifically promote responsibly sourced 
and produced FM and FO. The Global Aquaculture Alliance (GAA) Best Aquaculture Practices 
(BAP) standards (http://www.gaalliance.org/bap/standards.php) has several certification processes 
including a Feed Mills BAP Standard that addresses FM and FO conservation with responsible 
sourcing from approved certified sources. Finally, the Aquaculture Stewardship Council (ASC; 
http://www.asc-aqua.org) operates a certification and labeling programme to promote responsibly 
farmed seafood. Increasing adoption and implementation of these standards will further improve 
sustainability but also likely have impacts both for the supply of FM and FO and their use in 
aquaculture.  
   The presence of contaminants/undesirables such as persistent organic pollutants (POPS) including 
dioxins and PCBs is another potential constraint, at least with some marine ingredients (Tocher, 
2009; FAO/WHO, 2011). In general, this is an issue that had been diminishing to some extent with 
the increasing replacement of dietary FM and FO that meant levels of these undesirable marine 
environmental contaminants in feeds were decreasing and unlikely to increase in the future 
(Berntssen et al., 2010). However, this issue has been raised again with the recent announcement 
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(http://www.marineharvest.com/about/news-and-media/news/marine-harvest-salmon-even-
healthier/) indicating that at least one international fish farming company is planning to utilise only 
feed formulated with “cleaned” FO (Olli et al., 2010). It remains to be seen whether or not this is an 
overall beneficial development for aquaculture and, in particular, salmon farming. 
 
3. Roles of n-3 LC-PUFA in vertebrates 
3.1 Metabolic pathways for the biosynthesis LC-PUFA 
     The LC-PUFA are most commonly defined as PUFA with ≥ C20 and ≥ 3 double bonds and, 
although not a perfect definition, it includes all the main biologically active LC-PUFA such as EPA, 
DHA and arachidonic acid (ARA, 20:4n-6) and also includes other important n-3 fatty acids such as 
docosapentaenoic acid (DPA, 22:5n-3) and 20:4n-3 (Tocher, 2003). As PUFA (all fatty acids with 2 
or more double bonds) cannot be synthesised de novo in vertebrates due to the lack of Δ12 (or ω6) 
and Δ15 (or ω3) desaturases responsible for the production of PUFA from 18:1n-9, they are 
required to be supplied in the diet (Sargent et al., 2002). However, C18 PUFA such as α-linolenic 
acid (LNA, 18:3n-3) and linoleic acid (LOA, 18:2n-6) can be converted to the biologically active 
LC-PUFA in vertebrates although this varies with species dependent upon the presence and 
expression of genes of fatty acid desaturation and elongation (Tocher, 2003) (Fig. 2). In 
consequence, which PUFA can satisfy essential fatty acid (EFA) requirements varies similarly with 
species (Tocher 2010). 
 
3.2 Metabolic roles of LC-PUFA 
     Like all fatty acids, LC-PUFA have important structural roles as constituents of phospholipids 
that are the major components of cellular biomembranes, and confer various functional properties 
by affecting both physico-chemical properties of the membrane (e.g. fluidity) as well as influencing 
membrane protein (e.g. receptors, carriers and enzymes) functions (Tocher, 1995). Similarly, as 
components of triacylglycerols (TAG) and other storage lipids such as wax esters, LC-PUFA can 
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function as an energy reserve, with energy recovered through fatty acid β-oxidation in mitochondria 
(Tocher, 2003).  In addition, however, underpinning the essentiality of PUFA, LC-PUFA have more 
specific functional roles as important regulators of metabolism either as themselves or their 
derivatives. Regulation can be extracellular at the level of tissues through LC-PUFA derivatives 
including eicosanoids such as prostaglandins, leukotrienes, lipoxins, resolvins and protectins, or 
intracellular as ligands for transcription factors that control gene expression (Tocher, 2010). These 
regulatory roles underpin the importance of LC-PUFA as belonging to either the n-6 or n-3 series, 
the concept of balance in dietary intake of the two PUFA series that cannot be interconverted in 
vertebrates (see Fig.2), and the impact that dietary LC-PUFA can have on both health and disease 
(Lands, 2014). 
 
3.3 Roles of n-3 LC-PUFA in human health 
 It has long been appreciated that dietary n-3 LC-PUFA can have important, generally beneficial 
effects on human health largely based on two main lines of evidence, epidemiological studies and 
randomised controlled (intervention) trials, although laboratory studies investigating biochemical 
and molecular mechanisms can also support these approaches (Gil et al., 2012). 
3.3.1 Cardiac and cardiovascular disease (CVD)  
Epidemiological studies, that are normally large and long, looking at n-3 LC-PUFA intake 
(fish/fish oil) and/or status (blood/tissue fatty acid compositions) almost uniformly show a 
protective effect, decreasing the risk of developing CVD (Delgado-Lista et al., 2012). When 
all confounders are controlled the data are robust albeit they show only an “association” and 
not “cause and effect”. However, randomised controlled trials, normally designed for 
patients with some disease already (i.e. in at-risk patients), have also been generally positive 
and show that patients benefit from dietary n-3 LC-PUFA therapy (Calder and Yaqoob, 
2012; Delgado-Lista et al., 2012). Until recently, meta-analyses were also largely positive 
although there have been some recent studies showing less effect (Rizos et al., 2012; 
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Chowdhury et al., 2014). The biochemical mechanisms underlying the beneficial effects of 
n-3 LC-PUFA are primarily based on their lowering of known risk factors for CVD (blood 
cholesterol and TAG, hypertension) and effects on platelet function (Uauy and Valenzuela, 
2000). Molecular mechanisms are less well understood but include effects on hepatic lipid 
metabolism such as decreasing TAG synthesis, that involve, among other mechanisms, the 
important role of PUFA in transcriptional regulation of genes of lipid metabolism 
(Deckelbaum et al., 2006; Georgiadi and Kersten, 2012). Based on their effects on CVD, 
many health agencies worldwide recommend up to 500 mg/d of EPA and DHA for reducing 
CVD risk or 1 g/d for secondary prevention in existing CVD patients, with a dietary strategy 
for achieving 500 mg/d being to consume 2 fish meals per week with at least one of oily fish 
(ISSFAL, 2004; Gebauer et al., 2006; Aranceta and Perez-Rodrigo, 2012). 
 
3.3.2 Inflammatory disease 
 The most robust evidence for a beneficial effect of dietary n-3 LC-PUFA in inflammatory 
disease has been obtained in rheumatoid arthritis (Miles and Calder, 2012). The doses 
required to gain benefit are much higher than for CVD, at around 3g per day and so dietary 
n-3 LC-PUFA are still not part of classical treatment plans. There is also increasing 
evidence for beneficial effects of dietary n-3 LC-PUFA in Inflammatory Bowel Disease 
(IBD) such as Crohn’s disease and ulcerative colitis (Cabré et al., 2012). Although there are 
studies showing some beneficial effects of n-3 LC-PUFA in various other inflammatory 
diseases there are too few studies to be conclusive. In contrast, there is a very large body of 
research into the mechanisms of action of n-3 LC-PUFA on inflammatory pathways 
(Rangel-Huerta et al., 2012). Until recently, the major mechanism was thought to be the 
anti-ARA effect of n-3 LC-PUFA.  In brief, inflammatory responses are largely driven by 
eicosanoids produced from the major n-6 LC-PUFA, ARA, but other LC-PUFA, particularly 
EPA, compete with ARA at level of the cyclooxygenase (COX) and lipoxygenase enzymes 
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responsible for the production of eicosanoids, both reducing the production of pro-
inflammatory ARA derivatives and producing less inflammatory EPA-derived mediators 
(Calder, 2007). However, there is considerable research showing a wide range of 
mechanisms potentially underpinning the effects of n-3 LC-PUFA on inflammatory 
responses and immune pathways (Chapkin et al., 2009; Calder, 2013).  In particular in 
recent years, it has been established that the n-3 LC-PUFA, EPA and DHA, are also 
precursors of other COX-2 derived non-classical eicosanoid derivatives called resolvins, 
maresins and protectins, which are specialized pro-resolving mediators (PSM) that bring 
about resolution of the inflammatory response and a return to homeostasis (Serhan and 
Petasis, 2011; Weylandt et al., 2012). In addition, as ligands of various transcription factors, 
n-3 LC-PUFA and their derivatives can also have affects on expression of genes in 
inflammatory and immune pathways (Chapkin et al., 2009; Schmuth et al., 2014). 
Therefore, n-3 LC-PUFA have a combination of effects acting to reduce the respiratory 
burst and increase resolution (Calder, 2013). While ARA-EPA competition and the effects 
of n-3 LC-PUFA on eicosanoid production (Montero and Izquierdo, 2011; Martinez-Rubio 
et al., 2013) and inflammatory and immune gene expression have also been studied in fish 
(Montero and Izquierdo, 2011; Martinez-Rubio et al., 2012, 2014), the role of EPA and, 
especially, DHA in the production of SPM has not been studied in fish.  
 
3.3.3 Neural development 
 There is good robust evidence that decreased DHA status can lead to cognitive and visual 
impairment and that DHA supplements have positive beneficial outcomes in pre-term 
infants (Carlson et al., 1993). In term infants, DHA supplementation appears less effective 
suggesting that it is rectifying low DHA status that is effective rather than increasing 
“normal” DHA status (Campoy et al., 2012). There have also been several reports of 
potential beneficial effects of dietary DHA supplementation in a number of 
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psychological/behavioural/ psychiatric disorders including attention deficit hyperactivity 
disorder (ADHD) and depression and, although there are some reports of benefits, there are 
insufficient studies and data to draw firm conclusions (Ortega et al., 2012). However, it is 
becoming generally recognized that n-3 LC-PUFA are potential key nutrients to prevent 
various pathological conditions associated with the normal aging process (Ubeda et al., 
2012). This has prompted research into the effects of n-3 LC-PUFA on dementia, including 
Alzheimer’s disease (AD) and other age-related cognitive impairments (Dangour et al., 
2012). In general, there is a lack of agreement in findings from intervention studies to 
support a benefit of n-3 LC-PUFA on cognitive function but this may also reflect intrinsic 
limitations in the design of published studies (Dangour et al., 2012). However, DHA 
supplementation trials in patients with some pre-diagnosed cognitive impairment indicated 
that this appeared to slow AD progression (Quin et al., 2010). In long-term animal AD 
model trials, n-3 LC-PUFA improved cognitive function and diminished the amount of 
neuronal loss (Hooijmans et al., 2012).  As chronic inflammation is observed in AD, the 
mechanism of n-3 LC-PUFA is postulated to be due to down-regulation of inflammation and 
promotion of resolution of the inflammatory response (Hjorth et al., 2013).  
 
3.3.4 Cancer 
  Epidemiological studies have indicated that, in general, consumption of oily fish or taking 
n-3 LC-PUFA supplements may have a protective effect (i.e. decreasing risk) in colo-rectal, 
breast and prostate cancers (Gerber, 2012). Further evidence is difficult to obtain as 
randomised, controlled trials similar to those carried out in CVD are not possible in cancer, 
but there are studies indicating some beneficial effects of n-3 LC-PUFA supplementation in 
chemotherapy (Bougnoux et al., 2009). In small lung carcinoma, n-3 LC-PUFA appear to 
sensitise cancerous cells to chemotherapeutants thus increasing efficiency and perhaps 
decreasing side effects, enabling the patient to undergo more cycles (Murphy et al., 2011a). 
  13 
In addition, n-3 LC-PUFA may protect against the muscle mass loss likely due to hyper-
metabolism promoting proteolysis that is often associated with cancer (Murphy et al., 
2011b). The mechanisms underlying the latter two beneficial effects are not understood, but 
are possibly based on the effects of n-3 LC-PUFA on inflammatory processes. 
 
3.3.5 Negative reports 
 Two recent studies have associated n-3 LC-PUFA status with prostate cancer (Brasky et al., 
2011, 2013). The interpretation of these data has been criticized on a number of grounds 
including the fact that n-3 LC-PUFA intake was not monitored in these studies and, as n-3 
LC-PUFA supplementation is not uncommon in cancer patients (see above), the reason for 
the observed association between n-3 LC-PUFA and prostate cancer cannot be established. 
However, these negative reports have impacted on sales of FO-derived n-3 LC-PUFA 
products for direct human consumption and halted the ever-increasing trend over the last 
few years that peaked at 25 % of total FO in 2010-11, but that slipped back to 22 % in 2012 
(IFFO, 2013). More generally, negative effects of dietary n-3 LC-PUFA have been 
attributed with the pro-oxidant effect of LC-PUFA (Garrido et al., 1989; Tsuduki et al., 
2011). This can occur through the use of dietary sources that already contain oxidized lipids 
if not prepared/stored properly with appropriate anti-oxidant protection, but also through 
pro-oxidant effects in vivo (Albert et al., 2013; Garcia-Hernandez et al., 2013). Increased 
lipid oxidation products and anti-oxidant defence mechanisms (enzymes etc.) are both 
generally observed in n-3 LC-PUFA supplementation trials, and the need to also increase 
anti-oxidant intake when on supplements is well known. However, a certain level of 
“peroxide tone” is required for eicosanoid biosynthesis (Smith, 2005), and there is also 
evidence that n-3 LC-PUFA can have anti-oxidant actions (Giordano and Visoli, 2014). 
 
4. Fish, aquaculture and n-3 LC-PUFA  
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The above summary highlights the roles of n-3 LC-PUFA in health and in preventing and/or 
mitigating disease. However, whereas the public now have a good appreciation of the problems 
with human diets today in terms of too high levels of fat, saturated fat and cholesterol, there is far 
less understanding of fatty acids and “omega-3”. Evidence suggests that human beings evolved on a 
diet with a ratio of n-6 to n-3 PUFA of about 1:1, whereas modern so-called “Western” diets have a 
ratio of up to 20-25:1, indicating that diets are deficient in n-3 PUFA compared with the diet on 
which humans evolved and their genetic patterns were established  (Simopoulous, 2011). 
Considering the key roles of LC-PUFA in controlling and regulating lipid metabolism and, 
especially, inflammatory/immune responses, the dietary imbalance n-6 and n-3 PUFA is critical. 
Therefore, there is a need to rebalance our dietary intakes. The n-6/n-3 PUFA ratio in global oil and 
fat supply can be calculated from the data for individual oil/fat production (Gunstone, 2011) and oil 
fatty acid compositions (Gunstone and Harwood, 2007) to be around 24:1 post-hydrogenation 
(Gunstone, personal communication), Therefore, it is difficult to greatly reduce dietary intake of n-6 
PUFA, although this a key element of the Mediterranean diet rich in olive oil.  Increasing n-3 PUFA 
intake is entirely feasible, but LNA has relatively little functional role, other than as a precursor of 
EPA and DHA, and the LC-PUFA biosynthesis pathway is not very active in humans (Brenna et al., 
2009). Therefore, increasing n-3 LC-PUFA intake is the most efficient strategy to redress dietary 
PUFA imbalance as the biological effects largely reside with them. Fish and seafood traditionally 
supplied our dietary n-3 LC-PUFA, not because fish themselves produce them, but because aquatic 
food webs are n-3 LC-PUFA rich and, as 96 % of global water is ocean, EPA and DHA are 
predominantly of marine origin and fish simply accumulate them (Bell and Tocher, 2009a; Tocher, 
2009). By formulating feeds with FM and FO, aquaculture simply replicated this diet and so farmed 
fish were also rich in n-3 LC-PUFA. However, from 2000-2012 aquaculture has grown, on average, 
by 6.2 % annually and has been the fastest growing animal protein production sector for many years 
and, indeed, is outpacing population growth (FAO, 2014).  In contrast, as described above, FM and 
FO are finite resources and FO supply in particular would have limited this growth in aquaculture if 
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these marine products were not increasingly replaced in aquafeeds by alternative ingredients, 
predominantly terrestrial crop-derived plant meals and vegetable oils (Gatlin et al., 2007; Hardy, 
2010; Turchini et al., 2011a). The necessity to reduce the level of FO use prompted considerable 
research into the development of sustainable feeds and feeding strategies to maintain n-3 LC-PUFA 
levels in farmed fish despite the lower level of dietary n-3 LC-PUFA (Turchini et al., 2009, 2011a; 
Sales and Glencross, 2011). As a result, although modern aquafeeds contain far lower levels of both 
FM and FO, a recent study showed farmed salmon remain one of the best sources of EPA + DHA 
for human consumers (Henriques at al., 2014). Although the relative proportions of EPA and DHA 
were lower in farmed salmon products than in wild salmon products (Fig. 3A, C), in absolute terms 
the farmed salmon delivered, on average, double the dose of EPA and DHA than the wild salmon 
(Fig. 3B, C).  Therefore, the recommended dose (500 mg/d or 3.5 g/week) of EPA and DHA for 
lowering risk of CVD could be achieved by eating two 150 g portions of farmed salmon, whereas 4-
5 portions of wild salmon would be required (Henriques et al., 2014). 
 
5. Fish nutrition and n-3 LC-PUFA requirements 
As mentioned above, fish like all vertebrates require a dietary source of PUFA. The qualitative and 
quantitative EFA requirements of fish are reported in detail in earlier reviews (Glencross, 2009; 
Tocher, 2010) and are discussed in detail in the recently updated NRC volume on the Nutrient 
Requirements of Fish and Shrimp (NRC, 2011). Briefly, EFA requirements can be satisfied 
generally by C18 PUFA in freshwater and salmonid species whereas marine species require LC-
PUFA, EPA, DHA and ARA (Tocher, 2010). In species where requirements can be satisfied by C18 
PUFA, LC-PUFA can satisfy at a lower level, and requirements tends to be greater in early life 
stages (larvae) when the relative proportions of LC-PUFA (EPA, DHA and ARA) are particularly 
important (Tocher, 2010). Quantitative EFA requirements can be described on three levels. The 
physiological EFA requirement is the level to prevent classical nutritional pathology (EFA 
deficiency signs) and this is low, often around 1 % of the diet, or possibly lower if supplied by LC-
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PUFA. The published EFA requirement data for fish species probably represent good estimates of 
this requirement level (Glencross, 2009; Tocher, 2010). However, many early EFA studies were 
performed in small fish fed diets with relatively low lipid level for relatively short durations at a 
time when growth expectations were lower. Now, modern high-energy (lipid) diets and the 
consequent higher growth rates suggest that EFA requirements should perhaps be reassessed (NRC, 
2011). Therefore, there may be a higher level of EFA requirement to support optimum growth and 
health, although this is currently not well defined for any species and would likely vary dependent 
upon other dietary factors and fish metabolism (Tocher, 2003). The final requirement level is that to 
maintain nutritional quality based on n-3 LC-PUFA content of the flesh (Tocher, 2009). As such, 
this is not a requirement of the fish at all, but rather that of the human consumers (Simopoulos, 
2000). To satisfy this level, EPA and DHA need to be supplied well in excess of the requirements 
for optimal health and growth of the fish so that they are deposited and stored in fish lipid. 
 
6. Influence of endogenous metabolism on n-3 LC-PUFA levels in fish  
The fatty acid composition of fish is dependent upon the interaction of diet (prey or feed fatty acid 
compositions) with endogenous metabolism. The above discussion focussed on diet and this section 
now describes the potential influences that metabolism can have on n-3 LC-PUFA composition and 
content in farmed fish. 
 
6.1.Digestion and absorption 
The efficiency of digestion and absorption of nutrients is quantified by measuring Apparent 
Digestibility Coefficients (ADC), which are estimated by comparing dietary and faecal nutrients in 
comparison to an indigestible marker (Bell and Koppe, 2011). The ADCs of all PUFA, including 
LC-PUFA, are usually high for most fish species, but they can vary dependent upon dietary lipid 
content, fatty acid composition, chemical form (TAG, phospholipid), and temperature (Bell and 
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Koppe, 2011). However, in general, this means that dietary PUFA are efficiently digested and 
absorbed and therefore these processes do not greatly influence dietary fatty acid compositions.  
 
6.2 Oxidation 
In vitro studies comparing relative oxidation rates of fatty acids have suggested a rank order for 
oxidation of saturated/monounsaturated fatty acid  > PUFA > LC-PUFA, with n-6 > n-3, and 
shorter chain  > longer chain within saturated fatty acids at least (Henderson, 1996).  However, in 
vivo studies investigating fatty acid deposition in comparison to dietary intake show that the higher 
the concentration of a fatty acid in the diet, generally the lower its relative deposition, which 
implies increased (dietary) concentrations result in increased oxidation (Stubhaug et al., 2007). 
These studies indicate that oxidation of a fatty acid is a balance between enzyme specificities and 
substrate fatty acid concentrations (competition) with the latter appearing to dominate. This is 
generally the case for most PUFA including EPA, and so oxidation increases with increased dietary 
concentration, with generally no preferential retention (Stubhaug et al., 2007). The only general 
exception is DHA that is consistently shown to be deposited in tissues such as flesh and liver at 
higher levels than dietary inclusion showing it is preferentially retained (Brodtkord et al., 1997; 
Glencross, 2009). This is likely simply due the fact that the Δ4 double bond in DHA is resistant to 
mitochondrial β-oxidation, requiring peroxisomal oxidation to be removed, and this means it is not 
as easily oxidised as other fatty acids (Madsen et al., 1999). 
 
6.3 LC-PUFA biosynthesis 
As alluded to earlier, although LNA and LOA must be obtained in the diet, there are pathways for 
the endogenous production of LC-PUFA from C18 PUFA in fish, although the activity of these 
pathways is dependent upon the genes (enzymes) present (Fig. 1). The same enzymes operate on 
both n-3 and n-6 fatty acids and so there must be competition between the two PUFA series 
although, recently, it was shown that LOA had little effect on LNA bioconversion in rainbow trout, 
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Oncorhynchus mykiss (Emery et al., 2013). The biosynthesis of LC-PUFA should be looked upon 
as two separate pathways with EPA being the common component. The EPA pathway, production 
of EPA from LNA, requires two desaturations via a Δ6/Δ8 desaturase (depending upon whether 
LNA is first elongated or not) and a Δ5 desaturase (Cook and McMaster, 2004).  The DHA 
pathway, production of DHA from EPA, can proceed directly through elongation and Δ4 
desaturation or via the “Sprecher shunt” that involves elongation to 24:5n-3, Δ6 desaturation (by the 
same Δ6 as in the EPA pathway), and peroxisomal chain shortening (Sprecher, 2000).  The 
molecular components, fatty acyl desaturase (Fads) and elongase (Elovl) genes, transcripts and 
enzymes, involved in the pathways, their fatty acyl specificities, activities, species and tissue 
distributions have been described and discussed in detail in several recent reviews (Bell and Tocher, 
2009a; Tocher, 2010; Torstensen and Tocher, 2011; Monroig et al., 2011a, 2013; NRC, 2011) and 
so the present review will only focus on the most relevant aspects.  
    The EPA pathway in teleost fish is often incomplete, primarily due to a lack of Δ5 desaturase, 
and so synthesis of EPA from LNA is not possible in many, particularly marine, carnivorous 
species  (Tocher, 2010). However, the DHA pathway from EPA is probably functional in most 
teleost fish, including marine species, at least in some tissues such as brain (Tocher et al., 2006; 
Zheng et al., 2009; Monroig et al., 2011a). Salmonids and many freshwater species have complete 
pathways and can produce both EPA and DHA from LNA (Tocher, 2010; Monroig et al., 2011a). 
The expression of Δ6 and Δ5 desaturase and some elongase genes are subject to nutritional 
regulation and are up-regulated, generally by up to 2-3–fold, in fish fed VO-based diets compared 
to fish fed FO-based diets (Leaver et al., 2008a; Torstensen and Tocher, 2011; Vagner and 
Santigosa, 2011) and this has been shown to produce a similar increase in LC-PUFA biosynthesis in 
liver and intestinal tissues in salmonids (Zheng et al., 2004, 2005; Torstensen and Tocher, 2011).  
The up-regulation in fish fed VO is likely due mainly to relieving the suppression of gene 
expression exerted by dietary LC-PUFA, especially DHA (Leaver et al., 2008b; Thomassen et al., 
2012), although increased substrate (e.g. LNA) concentration may also stimulate expression 
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(Cleveland et al., 2012). Either way, dietary PUFA are likely to exert their effects through 
molecular mechanism(s) involving their role as ligands of key transcription factors such as sterol 
regulatory element binding proteins (SREBP) (Minghetti et al., 2011; Carmona-Antoñanzas et al., 
2014). Irrespective of mechanism, the up-regulation of LC-PUFA biosynthesis is not sufficient to 
maintain tissue EPA and DHA in fish fed VO-fed at the same level as in fish fed FO (Bell and 
Tocher, 2009b; Tocher et al., 2011). This is entirely expected as metabolic pathways such as LC-
PUFA have evolved to satisfy the requirements of the fish, not of human beings. Therefore, the 
differences between freshwater/salmonid and marine species in the EPA pathway are probably a 
consequence of the differing levels of LC-PUFA in the respective environments (higher in marine) 
leading to different evolutionary pressures, and are reflected in their qualitative EFA requirements 
(Leaver et al., 2008b; Carmona-Antoñanzas et al., 2013). DHA production from EPA is more 
conserved although there are few data, but this pathway is likely important particularly for brain 
development and function and, again, an evolutionary adaptation (Zheng et al., 2009). In species 
with complete LC-PUFA pathways such as salmonids, endogenous biosynthesis is sufficient to 
satisfy the relatively low levels of their normal physiological requirements, and there has been no 
biochemical/metabolic driver or evolutionary pressure to synthesise excess EPA and DHA just to be 
deposited in TAG and stored (Leaver et al., 2008b; Castro et al., 2012).  
      
6.4 Practical applications 
Therefore, fatty acid metabolism appears to impose more limitations than opportunities for 
enhancing n-3 LC-PUFA levels in fish. Can anything practical be done within the limitations 
imposed? 
 
6.4.1. Enhancing endogenous LC-PUFA production and retention  
There are two main options for enhancing endogenous LC-PUFA production and/or 
retention in fish using either a nutritional/biochemical/pharmacological approach or a 
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transgenic approach. The former alterantive was based on finding a nutritional strategy 
(careful formulation, fatty acid ratios etc.) or a specific dietary supplement (chemical or 
biochemical) that would increase LC-PUFA biosynthesis and/or retention by mechanisms 
such as influencing gene expression or enzyme activities (Torstensen and Tocher, 2011). 
Nutritional strategies such as carefully formulating diets with “optimal” C18 PUFA or 
micronutrient levels have been researched, particularly in trout, and have been successful in 
altering the efficiency of LC-PUFA production (Turchini et al., 2011b; Lewis et al., 2013). 
Dietary supplementation has been investigated with bioactive fatty acids (conjugated 
linoleic acid, 3-thia acids, petroselinic acid), fibrates and other botanicals, such as the lignin 
sesamin, with some limited success including increasing LC-PUFA biosynthesis (Ruyter et 
al., 1997; Moya-Falcón et al., 2004; Kennedy et al., 2006; Trattner et al., 2008a,b; Randall 
et al., 2013). However, any uplift in biosynthetic activity observed in the above studies has 
been relatively small and insufficient to compensate for the lack of dietary LC-PUFA.  
    Genetic modification (GM) is another potential option for increasing endogenous 
production or retention of n-3 LC-PUFA in farmed fish (Maclean and Laight, 2000). Proof 
of concept of GM to enhance production characteristics in farmed fish already exists as 
transgenic lines transformed with growth hormone/promoter genes have been produced that 
demonstrate growth enhancement in several species, including Atlantic salmon (Devlin et 
al., 2004). There have also been research studies in fish specifically targeting LC-PUFA 
metabolism.  Transgenic zebrafish (Danio rerio) have been produced by transformation with 
Δ6 and Δ5 fatty acyl desaturases of masu salmon (Oncorhynchus masou) (Alimuddin et al., 
2005, 2007), and both zebrafish (Alimuddin et al., 2008) and the marine teleost, nibe 
croaker Nibea mitsukurii (Kabeya et al., 2014), have been transformed with fatty acid 
elongase from masu salmon. Recently, the production of n-3 PUFA, specifically LNA from 
18:1n-9, was demonstrated in GM-zebrafish transformed with fat-1 and fat-2 genes (Pang et 
al., 2014). However, in all these studies the increments in EPA and DHA levels have been 
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small and so this enhancement, by a combination of adding function and/or overexpression 
of biosynthetic genes, may have limitations based on the metabolic and physiological 
controls of the biochemical pathways. Furthermore, the production and use of GM fish is 
likely to face many socio-political, ecological and environmental challenges before it could 
become commercially viable.  
 
6.4.2 Genetic Selection 
It was recently shown that flesh n-3 LC-PUFA level is a heritable trait in salmon (Leaver et 
al., 2011) and therefore it could be beneficial to introduce this trait into selective breeding 
programmes (Gjedrem, 2000). The differences in levels of n-3 LC-PUFA in flesh between 
different families/strains reported so far are relatively small (2-3 % of total fatty acids) 
(Morais et al., 2012a), but it demonstrates that there is scope for this strategy and the 
variability that may exist in wild populations is simply not known. Therefore, although the 
current knowledge of the variability in this trait would suggest this could not be a solution to 
the issue of reduced dietary n-3 LC-PUFA in farmed fish, it is nonetheless a sensible 
approach to select for this trait to optimise the efficiency of n-3 LC-PUFA metabolism and 
flesh levels, irrespective of likely dietary levels in the future. 
 
7. The supply of n-3 LC-PUFA for aquaculture  
The above discussion has concluded that lipid and fatty acid metabolism in fish is fundamentally 
limited by biochemistry and physiological control mechanisms such that a solution to maintaining 
high n-3 LC-PUFA levels in tissues when dietary levels are low is unlikely be found within the fish 
itself. This returns us full circle to dietary supply as the only viable option for maintaining high 
levels of n-3 LC-PUFA in farmed fish. 
 
7.1 The real problem of FO as a source of n-3 LC-PUFA for aquaculture 
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 The use of FO (and FM) as sources of n-3 LC-PUFA was a perfectly sensible approach 30-40 years 
ago during the initial the development of intensive aquaculture.  Both marine ingredients were 
readily accepted and digested by fish, had favourable nutrient compositions and, simply put, they 
represented the natural food for the fish (NRC, 2011). Furthermore, FM and FO are just 
commodities similar to other raw materials or primary agricultural products that have long-since 
been globally produced and marketed, and aquaculture simply grew to become the biggest customer 
for these marine resources (Jackson and Shepherd, 2013). However, the danger of stagnating 
fisheries and growing aquaculture with an over-dependence on a limited range of feed ingredients, 
and the issues and difficulties of replacement, especially of FO, have been appreciated for many 
years (Sargent and Tacon, 1999; Naylor et al., 2000). Analyses of fish-in fish-out (FIFO) ratios of 
aquaculture production was developed as a potentially useful tool in assessing the use of marine 
ingredients. Although this analyses showed that FIFO for the aquaculture of all fed species 
combined had decreased from 1.0 in 1995 to about 0.7 in 2006 with a further projected decrease 
towards 0.2 by 2020 (Tacon and Metian, 2008), the ratio was embraced by environmental and anti-
fish farming groups to wrongly imply that aquaculture, particularly salmon farming, was an 
inefficient practice wasting precious marine resources. The methodology for calculating FIFO 
(Kaushik and Troell, 2010) and the initial high values of 4-5:1 for salmon farming (Tacon and 
Metian, 2008) have been challenged (Jackson, 2009), and it has been suggested that FIFO should be 
replaced by marine nutrient dependency ratios for which the amount of each marine nutrient used in 
feed is divided by the amount of that nutrient in the farmed product, producing separate ratios for 
protein (MPDR) and oil (MODR) (Crampton et al., 2010). However, the fundamental flaw with 
FIFO ratio is that it has no nutritional basis and is in no way a measure of production efficiency. It 
is well established that aquaculture is generally very efficient and top performing species like 
Atlantic salmon (Torrissen et al., 2011) have a lower feed conversion ratio (FCR) than any 
terrestrial animal production with commercial values of 1.1 to 1.2 compared to ~2 for poultry, ~3 
for pigs, and > 6 for lamb and beef (Shepherd and Little, 2014). In addition, salmon show higher 
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protein and energy retentions, and harvest and edible yields than terrestrial meat production 
(Shepherd and Little, 2014). The only practical use that a FIFO can serve is perhaps as a monitor of 
how different aquaculture sectors are developing because, overall, with expanding production and 
finite supplies of FO (and FM), the only way is down for FIFO. Indeed, it has been recently 
demonstrated that Atlantic salmon can be a net producer of both marine protein (Crampton et al., 
2010; Bendiksen et al., 2011) and n-3 LC-PUFA (Sanden et al., 2011; Turchini et al., 2011b), 
although for the latter it should be stressed that the levels of n-3 LC-PUFA in the products are far 
lower than those in fish fed FO. 
     The real problem with FM and, especially, FO, as with many commodities, is supply and 
demand. What was not sustainable was the use of high volumes of finite resources, which is not 
suggesting that FO and FM are themselves unsustainable resources (Jackson and Shepherd, 2013). 
The sustainability of the industrial/reduction fisheries is no different to any other fishery in the 
world. To be sustainable, all fisheries have to be managed and regulated (FAO, 2005), as they are in 
for many species in several areas including S. America and Europe (Jackson and Shepherd, 2012). 
Application of the IFFO-RS standard to the whole marine ingredient/resource sector, including 
Asia, although challenging, is continuing and represents real improvement (IFFO, 2012). However, 
FO and FM supplies will always be finite and limiting. As FO (and FM) are the primary sources, 
this implies that the current global supply of n-3 LC-PUFA is similarly finite and limited, and the 
gap between supply and demand can be estimated. Based on the recommended dose for cardiac 
health, the total demand for n-3 LC-PUFA is over 11/4 million metric tonnes (mt) whereas total 
supply is optimistically estimated at just over 0.8 million mt indicating a shortfall of over 0.4 
million mts (Table 1). The majority of supply (almost 90 %) is from capture fisheries, whether as 
food fish or via FO and FM, with relatively small additional amounts realistically estimated from 
seafood by-products and recycling, unfed aquaculture and algal sources. While it is acknowledged 
that the calculations in Table 1 contain some assumptions and estimates, and the precise extent of 
the difference can be the argued, the fact that the gap exists is not in question irrespective of how it 
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is calculated (Naylor et al., 2009). There is a fundamental, global lack of n-3 LC-PUFA to supply 
all human needs, whether by direct consumption or via aquaculture.  
 
7.2 Alternative sources of n-3 LC-PUFA 
7.2.1 Other oils of marine origin 
Possible alternative marine sources for oils include utilising lower trophic levels, specifically 
zooplankton such as krill and calanoid copepods in the southern and northern hemispheres, 
respectively, and mesopelagic fish. The biomass at lower trophic levels is large, but there are 
inherent dangers associated with fishing down the marine food web (Pauly et al., 1998). 
    The utilisation of krill and copepods has been studied and, in general, zooplankton can be 
potentially good lipid sources (Olsen et al., 2011). However the harvesting of krill and copepods 
poses significant technological challenges and cost. For most species, lack of schooling behaviour 
makes harvest by traditional trawling technology an expensive economic option (Olsen et al., 
2011). Antarctic krill, which do form schools, is the only species being targeted for commercial 
harvest, apart from a small scientific quota (~1000 mt) of the calanoid copepod, Calanus 
finmachicus (Croxall and Nicol, 2004). MSC-certified krill meal up to 10% is currently being used 
in some salmon feeds during the seawater phase in both Norway and Scotland as the higher growth 
rate and consequent shorter cycle compensates for the increased cost. Other feeds can have krill 
meal at even higher levels, but these are premium feeds focussed on health benefits and are used 
sparingly. Therefore these krill products are not being used as primary sources of n-3 LC-PUFA. 
Currently, krill lipid products are used almost exclusively for the human nutraceutical market.  
Although there may be evidence that harvesting krill, and potentially copepods, could be 
sustainable, there are still significant environmental and ecological concerns (Olsen et al., 2011). 
For instance, Antarctic krill are near the base of a food chain that includes whales and penguins that 
would suggest there could be opposition to greatly increased exploitation (Hill et al., 2006). 
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Copepods have an additional problem, as the oil is rich in wax esters rather than TAG, which may 
limit its widespread use (Olsen et al., 2004; Bogevik et al., 2010). 
      Mesopelagic fish that inhabit the intermediate pelagic water masses between the euphotic zone 
at 100 m depth and the deep bathypelagic zone at 1000 m are available in potentially large 
quantities (1 - 6 billion mt), with lantern fish, myctophids, constituting about 60 % of biomass 
(Irigoien, 2014). Different species can contain between 16 and 60 % of dry weight (Falk-Petersen, 
1986; El-Mowafi et al., 2010) as lipid that can be in the form of TAG or, in some species, wax 
esters and, regardless of species, they are all good sources of n-3 LC-PUFA (Olsen et al., 2011). On 
the positive side, they are resources that, so far, have not been the subject of commercial 
exploitation, and they do not compete with existing or potential human feed production. Negative 
points include biological (seasonal variation), ecological (mixed fishery difficult to manage), 
technical (capture methods and on-board processing), and nutritional (wax esters) issues. 
 
7.2.2.By-catch and seafood processing by-products 
 In almost all fisheries there are non-target catch and/or discarded target catch that, together, make 
up the by-catch. However, both the precise definition and resultant estimates of by-catch can be 
controversial (FAO, 2009). In 2005, the discard rate was estimated at around 7 million mt/year or 8 
% of global catch (Kelleher, 2005). By its nature, by-catch is a diffuse resource (Batista, 2007) and 
this imposes a major limitation to its usefulness as a source of FO, although processing of by-
products, including oil production, at sea is an increasing trend (Falch et al., 2007). Another 
limitation is that by-catch includes a multitude of species, not necessarily “oily”, which limits the 
quantity and quality (lipid class and fatty acid compositions, lipid soluble nutrients and 
contaminants) of the oils produced (Batista, 2007). 
    Another potential source of fish/marine oils is seafood industry by-products including 
viscera, heads, carcasses and trimmings, particularly those produced from pelagic fisheries and 
aquaculture. Whereas these by-products can produce significant amounts of FM (Lekang and 
  26 
Gutierrez, 2007), the production of oil is largely dictated by species. Thus, by-products from oily 
species including salmon, herring and mackerel can be a source of substantial FO whereas by-
products from other pelagic (white fish) fisheries have generally lower lipid contents (Lekang and 
Gutierrez, 2007). Liver from species like cod and halibut have traditionally been used for FO 
production, but production is now relatively small (~ 40,000 mt) and goes mostly for direct human 
consumption as vitamin A and D supplements as much as sources of n-3 LC-PUFA (Hertrampf and 
Piedad-Pascual, 2000). Oil is now being actively recovered from aquaculture species waste, 
particularly salmon farming, with around 20,000 mt reportedly recovered in Norway (Rubin, 2009), 
and 50,000 mt in Chile in 2006 (Tacon and Metian, 2008). 
Other limitations to the use of oils from aquaculture by-products include regulatory issues 
preventing intra-species use to prevent recycling of contaminants and disease transfer, and so oils 
from aquaculture are currently used either for human nutrition or other farmed species depending 
on quality (Skåra et al., 2004). In addition, recycled oils from freshwater aquaculture species 
including carps and tilapia can be of limited value due to the generally low levels of n-3 LC-PUFA 
(Borghesi et al., 2008). Overall, by-catch and seafood by-products are potential sources of FO and, 
although there is currently some production, the contribution of these sources to overall FO supply 
is not well quantified (Jackson and Shepherd, 2012; Shepherd and Jackson, 2013).  
 
7.2.3.Microalgae 
Potentially, culture of the main primary producers, marine microalgae, could offer the ideal long-
term, sustainable solution to the problem of n-3-LC-PUFA supply (Apt and Behrens, 1999). 
Various photosynthetic microalgae are already commonly used in hatcheries to supply both EPA 
(e.g. diatoms) and DHA (e.g. flagellates) to live feeds, rotifers (Brachionus spp.) and Artemia 
nauplii, for the rearing of larval marine crustacean and fish species (Muller-Feuga, 2004). 
Production usually employs medium- to high-density batch, semi-continuous or continuous culture 
in relatively small volumes (Stottrup and McEvoy, 2003). Up-scaling of production to the volumes 
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required for algal oil and/or algal biomass to supply the amount of n-3 LC-PUFA required to 
replace FO in commercial aquafeed production has very significant biological and technological 
challenges. Economic production of n-3 LC-PUFA would require algae to demonstrate 
simultaneous high growth and high lipid content with a high proportion of EPA and DHA. These 
can be almost exclusive traits as lipid deposition is often associated with conditions when growth is 
limited (e.g. N limitation) (Richmond, 2008). Technical challenges include efficient capture of light 
energy in high-density culture with effective temperature control. These issues remain to be solved 
but this is not to say that algal species with favourable biological characteristics cannot be found, 
and photo-bioreactor technologies may improve considerably in the future.  
      In contrast, heterotrophic microalgal species including Crypthecodinium and thraustochytrids 
such as Schizochytrium are already being utilised for the commercial production of DHA using 
large-scale biofermentor technology (Raghukumar, 2008). Even so, the high production costs are 
generally limiting the use of these products to direct human consumption mainly in the form of 
DHA supplementation of infant formulae (Ward and Singh, 2005). Research showed that 
substituting FO with thraustochytrid oil in the diet of Atlantic salmon parr significantly increased 
muscle DHA without any detriment to growth (Miller et al., 2007). Similarly, biomass from 
Schizochytrium and C. cohnii have been used to substitute for FO with no deleterious effects in 
larval microdiets and starter feeds for gilthead seabream (Sparus aurata) (Atalah et al., 2007; 
Ganuza et al., 2008). Currently, a thraustrochytrid algal biomass product (DHAgold, DSM, 
Maryland) containing around 18 % DHA (by weight) is commercially available and apparently 
being used in aquaculture (Miller et al., 2011). Therefore, these DHA-rich products from 
heterotrophic microalgae may have niche markets in marine hatcheries, particularly for high-value 
marine species. Production volumes would have to be increased and costs reduced before these 
products could be viable for wider application in aquaculture. Biochemically, Schizochytrium sp. 
are particularly interesting as they appear to have two alternative pathways for n-3 LC-PUFA 
biosynthesis (Lippmeier et al., 2009). Primary production of DHA and 22:5n-6 in Schizochytrium is 
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via a PUFA synthase (Metz et al., 2001), a series of 3 genes similar to those found in LC-PUFA-
producing marine bacteria (Yazawa, 1996; Morita et al., 2000). In addition, a series of aerobic 
PUFA desaturase and elongase genes are also present in Schizochytrium (Lippmeier et al., 2009). 
 
7.2.4 Transgenics  
As discussed above, it is unlikely that microalgal biomass can be produced on the scale necessary 
and at an economic cost to satisfy the demands of aquaculture for n-3 LC-PUFA, at least in the 
short- to medium-term (Miller et al., 2011). However, microalgae represent a highly valuable 
source of genes encoding for the biosynthetic enzymes required for n-3 LC-PUFA production 
(Venegas-Caleron et al., 2010). The overall strategy being to genetically modify existing organisms 
that have oil deposition as a major trait and thus combine this with the n-3 LC-PUFA biosynthesis 
trait. Potential candidates include other oleaginous microorganisms or conventional oilseed crops to 
produce entirely novel sources of de novo n-3 LC-PUFA (Zhu et al., 2010; Sayanova and Napier, 
2011). 
      Metabolic engineering of the oleaginous yeast Yarrowia lipolytica has resulted in a strain that 
produced EPA at 15 % of dry weight (Xue et al., 2013). It was shown that the EPA-Yarrowia cell 
mass was suitable as a feed ingredient for Atlantic salmon (Hatland et al., 2012) although disruption 
was required to increase the bioavailability of lipid and EPA (Berge et al., 2013). To the best of the 
author’s knowledge, the transgenic yeast oil or cell biomass are not yet fully commercially available 
although they appear to be used by aDuPont/AquaChile venture (Verlasso®) to produce a niche 
salmon product (http://futurefood2050.com/turning-yeast-into-sustainable-fish-food/).  However, as 
the production of the transgenic yeast uses biofermentor technology similar to that used for 
Schizochytrium, it appears unlikely that it could be produced in volumes and at a cost that would 
make it viable as a large-scale alternative to FO in aquaculture, at least in the short- to medium-
term. 
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        Oilseed crops dominate world oil production and there is a highly organised and well-
established infrastructure for the cultivation, harvest, processing, distribution, marketing and 
utilisation of vegetable oils (Salunkhe et al., 1992). Therefore, oilseed crops are highly practical 
platforms from which to develop a novel, renewable supply of n-3 LC-PUFA. However, 
conventional plant breeding strategies cannot be used as the genes required for LC-PUFA synthesis 
are simply not present in higher plants, leaving transgenesis as the only option for modification of 
oilseeds to contain LC-PUFA. Therefore, the only currently viable approach to developing a novel, 
renewable supply of EPA and DHA is the metabolic engineering of oilseed crops with the capacity 
to synthesise n-3 LC-PUFA in seeds (Haslam et al., 2013). Production of n-3 LC-PUFA in 
terrestrial plant seeds was demonstrated in the model plant Arabidopsis (Petrie et al., 2012; Ruiz-
Lopez et al., 2013), and very recently reported in an oilseed crop, Camelina sativa (Petrie et al., 
2014; Ruiz-Lopez et al., 2014). C. sativa or false flax, is a member of the Brassicaceae family and 
an ancient crop that, in the wild-type, produces an oil with LNA at up to 45 % of total fatty acids 
(Gunstone and Harwood, 2007). Transgenic C. sativa lines have now been developed by 
transformation with algal genes encoding the n-3 LC-PUFA biosynthetic pathway and expression 
restricted to the seeds via seed-specific promoters to produce oils with over 20 % of total fatty acids 
as n-3 LC-PUFA, either as EPA alone or as EPA + DHA (12 % + 8 %) (Ruiz-Lopez et al., 2014).  
      As well as being easily transformable by Agrobacterium floral infiltration, Camelina has 
additional desirable traits including modest input requirements (water and pesticides) and ability to 
thrive in semi-arid conditions (Tocher et al., 2011). In the US, several states are actively growing 
Camelina as a biofuels crop, indicating the wide acceptance of this crop platform. Furthermore, 
wild-type Camelina oil has already been shown to be suitable for inclusion in fish feeds and 
contains no anti-nutritional factors detrimental to fish growth (Petropoulos et al., 2009; Morais et 
al., 2012b; Hixson et al., 2014). Ultimately, all animal production will depend on terrestrial 
plants/agriculture and this requires land. However, it is pertinent to emphasise that the production of 
n-3 LC-PUFA in terrestrial oilseed crops should not require additional arable land as the ideal 
  30 
solution would be to switch some VO production from n-6 PUFA-rich crops to the new n-3 LC-
PUFA crops. However, irrespective of the advances in science, one of the greatest challenges, at 
least in Europe, will be to change public opinion towards acceptance of genetically modified 
products before these transgenic oils can be used commercially on a global scale. 
 
8. Conclusions 
Although PUFA in general are essential nutrients in vertebrates, it is the highly bioactive LC-PUFA 
that have the major critical metabolic functions including maintaining physiological homeostasis, 
cardiovascular health, inflammatory and immune responses and neural development. The 
qualitative EFA requirements of fish depend on the extent of endogenous LC-PUFA biosynthesis 
and so LNA can satisfy requirements in some species whereas EPA and DHA are required in 
others. Irrespective, the quantitative EFA requirements for optimal growth and health of fish are 
relatively low. In contrast, the level of dietary n-3 LC-PUFA required to maintain farmed fish as 
good sources of these nutrients for human consumers is high, and the finite and limited supply of 
FO, the principle source of EPA and DHA, and the lack of sustainable alternatives containing n-3 
LC-PUFA has posed a major challenge. Optimising n-3 LC-PUFA biosynthesis and retention in 
fish through nutritional strategies and genetic selection are sensible approaches for the efficient use 
of limited resources.  However, it is unlikely that metabolism or genetics of fish can be modulated 
or manipulated sufficiently to compensate for reduced dietary EPA and DHA. Therefore, alternative 
sources of dietary n-3 LC-PUFA are required. While novel marine sources and improved use of 
fisheries and seafood by-products can contribute in the short to medium term, the only long-term 
solution is an entirely new supply of de novo EPA and DHA. While mass culture of the primary 
producers, marine phototropic microalgae, would arguably represent the most natural solution, 
major biological and technological challenges remain to be solved. In the meantime, GM solutions, 
expressing algal genes in oleaginous platforms, are already developed with transgenic oilseed crops 
currently presenting the most effective solution for the large-scale production of EPA and DHA. 
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The science has been successful and the agricultural and industrial infrastructure is already in place 
and, although there are significant socio-political challenges to the acceptance of GM, particularly 
in Europe, other parts of the world will embrace this solution to the problem of n-3 LC-PUFA 
supply that transcends aquaculture and is important to everyone. 
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 Legends to Figures 
 
Fig.1. Current global use of fish oil. A. Major fates of fish oil in 2012; B. Consumption of fish oil 
by the various aquaculture sectors in 2012; C. Trend in volumes (million tonnes) of fish oil used by 
aquaculture and other sectors from 2005-2012.  
 
Fig.2. Pathways of long-chain polyunsaturated fatty acid biosynthesis in fish. All activities have 
been demonstrated in teleost fish species but not all species express all activities. The Δ8 
desaturation activity is an inherent characteristic of the Δ6 Fad of most teleosts, especially marine 
species (Monroig et al., 2011b). A discrete Δ5 Fad has only been isolated from Atlantic salmon 
although bifunctional Δ6Δ5 Fads have been characterised in zebrafish, rabbitfish, Siganus 
canaliculatus and Mexican silverside, Chirostoma estor (Hastings et al., 2001; Li et al., 2010; 
Monroig et al., 2014). The presence of Δ4 Fad enabling direct production of 22:6n-3 from 22:5n-3 
has been demonstrated in rabbitfish, Senegalese sole, Solea senegalensis and Mexican silverside, 
Chirostoma estor (Li et al., 2010; Morais et al., 2012c; Monroig, et al., 2014). The Sprecher shunt 
pathway via C24 fatty acid intermediates has been shown in trout (Buzzi et al., 1997) and the Δ6 
Fad of Atlantic salmon and zebrafish can operate on both C18 and C24 fatty acids (Tocher et al., 
2003). Δ4 Fad, Δ5 Fad and Δ6 Fad, fatty acyl desaturases; Elovl2, Elovl4 and Elovl5, fatty acid 
elongases. 
 
Fig.3. The relative proportions (percentage of total fatty acids, panel A), absolute contents (g / 100g 
flesh, panel B) and consolidated data (panel C) of EPA + DHA in farmed (grey bars) and wild 
(black bars) salmon products obtained from major UK retailers. On the x-axis, each letter represents 
a retailer and the following number denotes a specific product. Data are means ± S.D. (n = 2-4 
depending upon product for panels A and B; n = 34 and 12 for farmed and wild products, 
respectively, in panel C). Superscript letters in panel C represent significant differences between 
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farmed and wild products as determined by t-tests. Reprinted with permission (Henriques et al., 
2014). 
  
57 
Table 1. Potential annual demand for n-3 LC-PUFA based on recommended intake for secondary 
 prevention of CVD compared with global annual supply from major sources. 
       
 
  
Million 
tonnes Notes 
 Demand (3.5g/week x 52 weeks x 7 billion) 1.274 Based on 500 mg/day (ISSFAL, 2004) 
 Supply (see below) 0.84 Less than 2/3. See below for breakdown 
 Gap (Demand - Supply) 0.434 
  
    Capture fisheries (food) 
   Landed 75.0 FAO, 2014. 
 Edible yield (50%) 37.5 
  Lipid content (5%) 1.875 
  n-3 LC-PUFA content (20%) 0.375 
  
    Capture fisheries (feed) 
   Landed 20.0 FAO, 2014. 
 Fishmeal produced (22%) 4.4 Fishmeal yield generally constant at 22% 
 Lipid content (10%) 0.44 
  n-3 LC-PUFA content (25%) 0.11 
  Fish oil produced 1.0 Oil yield is variable 
 n-3 LC-PUFA content (25%) 0.25 
  
    Seafood by-products (incl. aquaculture) 
 
About 50 % of by-products are produced  
 Fishmeal produced 2.0 from aquaculture and, therefore, the  
 Lipid content (5%) 0.1 n-3 LC-PUFA is mainly  derived from 
 n-3 LC-PUFA content (10%) 0.01 fishmeal and fish oil and , as such,  
 Fish oil produced 0.2 already counted above. 
 n-3 LC-PUFA content (10%) 0.02 
  
    Aquaculture (unfed) 
 
Mainly filter-feeding carps (7.1 mt) and 
 Produced 20.5 bivalves (13.4 mt) (FAO, 2014) 
 Edible yield (50%) 10.25 
  Lipid content (5%) 0.525 
  n-3 LC-PUFA content (10%) 0.05 
  
    Aquaculture (endogenous production) NA Salmonids and fed freshwater species1 
 
    Macroalgae 
 
Including species used for carageenin, 
 Produced 23.8 algin, agar and iodine (~16 mt) 
 Food or feed use 7.0 Human consumption & aquaculture 
 Lipid content (2%) 0.14 
  n-3 LC-PUFA content (15%) 0.02   
 Production figures are from 2012 (FAO, 2014). All lipid and n-3 LC-PUFA contents/yields are estimated  
 averages over the wide range of species in each category.  
  1,Salmonids include salmon and trout spp. Freshwater species includes eels, tilapia and other freshwater 
 species that still utilise some fishmeal and fish oil (13% of total fish oil used in aquaculture) in feeds.   
 NA, not available. Although there will be some endogenous production of n-3 LC-PUFA inversely related 
 to fishmeal and oil contents of feeds, this cannot be accurately estimated, but will likely be minor based on 
 volume of fish oil consumed by these sectors (75 % of all fish oil used in aquaculture).  
 
  
58 
Fig. 1. 
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Fig. 2. 
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Fig. 3. 
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